COSM
Income statement / Annual
Last year (2023), Cosmos Health Inc.'s total revenue was $53.38 M,
an increase of 6.02% from the previous year.
In 2023, Cosmos Health Inc.'s net income was -$18.54 M.
See Cosmos Health Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$53.38 M
|
$50.35 M
|
$56.24 M
|
$55.41 M
|
$39.68 M
|
$37.08 M
|
$30.01 M
|
$6.76 M
|
$533,802.00
|
$7.64 M
|
| Cost of Revenue |
$49.03 M |
$44.39 M |
$47.91 M |
$47.35 M |
$36.01 M |
$34.68 M |
$28.06 M |
$6.15 M |
$484,809.00 |
$70,806.00 |
| Gross Profit |
$4.35 M |
$5.96 M |
$8.33 M |
$8.06 M |
$3.66 M |
$2.41 M |
$1.96 M |
$601,040.00 |
$48,993.00 |
$7.57 M |
| Gross Profit Ratio |
0.08 |
0.12 |
0.15 |
0.15 |
0.09 |
0.06 |
0.07 |
0.09 |
0.09 |
0.99 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$24.36 M
|
$12.61 M
|
$11.68 M
|
$4.19 M
|
$3.52 M
|
$3.59 M
|
$4.85 M
|
$794,099.00
|
$486,036.00
|
$513,767.00
|
| Selling & Marketing
Expenses |
$1.20 M
|
$630,057.00
|
$732,545.00
|
$763,170.00
|
$234,037.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$25.57 M
|
$13.24 M
|
$12.41 M
|
$4.95 M
|
$3.52 M
|
$3.59 M
|
$4.85 M
|
$794,099.00
|
$486,036.00
|
$513,767.00
|
| Other Expenses |
$614,377.00 |
$188,890.00 |
$449,692.00 |
$397,595.00 |
$394,628.00 |
$43,930.00 |
-$27,492.00 |
-$12,745.00 |
-$5,186.00 |
$9,478.00 |
| Operating Expenses |
$26.18 M |
$13.43 M |
$12.86 M |
$5.35 M |
$3.92 M |
$3.64 M |
$4.88 M |
$803,547.00 |
$491,452.00 |
$523,245.00 |
| Cost And Expenses |
$75.21 M |
$57.82 M |
$60.77 M |
$52.69 M |
$39.93 M |
$38.31 M |
$32.94 M |
$6.96 M |
$976,261.00 |
$523,245.00 |
| Interest Income |
$662,859.00 |
$236,349.00 |
$46,316.00 |
$65,865.00 |
$1.73 M |
$0.00 |
$0.00 |
$0.00 |
$1,063.00 |
$433.00 |
| Interest Expense |
$866,476.00 |
$3.97 M |
$3.58 M |
$2.80 M |
$1.73 M |
$6.81 M |
$1.64 M |
$206,014.00 |
$90,379.00 |
$74,336.00 |
| Depreciation &
Amortization |
$614,377.00
|
$188,890.00
|
$449,692.00
|
$397,595.00
|
$394,628.00
|
$43,930.00
|
$25,903.00
|
$9,448.00
|
$5,416.00
|
$9,478.00
|
| EBITDA |
-$17.06 M
|
-$8.90 M
|
-$3.82 M
|
$3.18 M
|
-$988,585.00
|
-$2.19 M
|
-$4.54 M
|
-$384,769.00
|
-$6.59 M
|
$7.13 M
|
| EBITDA Ratio |
-0.32 |
-0.19 |
-0.07 |
0.06 |
0.01 |
-0.03 |
-0.1 |
-0.03 |
-0.82 |
0.93 |
| Operating Income Ratio
|
-0.41
|
-0.15
|
-0.08
|
0.05
|
-0
|
-0.03
|
-0.16
|
-0.03
|
-0.83
|
0.93
|
| Total Other
Income/Expenses Net |
$3.29 M
|
-$5.58 M
|
-$3.31 M
|
-$1.52 M
|
-$2.86 M
|
-$7.81 M
|
-$3.28 M
|
-$397,726.00
|
-$6.25 M
|
-$73,903.00
|
| Income Before Tax |
-$18.54 M |
-$13.06 M |
-$7.85 M |
$1.20 M |
-$3.12 M |
-$9.04 M |
-$6.21 M |
-$600,233.00 |
-$6.69 M |
$7.04 M |
| Income Before Tax Ratio
|
-0.35
|
-0.26
|
-0.14
|
0.02
|
-0.08
|
-0.24
|
-0.21
|
-0.09
|
-12.53
|
0.92
|
| Income Tax Expense |
$0.00 |
$775,051.00 |
$114,010.00 |
$377,535.00 |
$182,815.00 |
$17,326.00 |
$2,801.00 |
$769.00 |
-$203.00 |
$997,183.00 |
| Net Income |
-$18.54 M |
-$13.83 M |
-$7.96 M |
$820,786.00 |
-$3.30 M |
-$9.06 M |
-$6.21 M |
-$601,002.00 |
-$6.69 M |
$6.04 M |
| Net Income Ratio |
-0.35 |
-0.27 |
-0.14 |
0.01 |
-0.08 |
-0.24 |
-0.21 |
-0.09 |
-12.53 |
0.79 |
| EPS |
-2.15 |
-7.17 |
-12.12 |
1.55 |
-6.21 |
-17.02 |
-12.25 |
-1.25 |
-13.31 |
12.5 |
| EPS Diluted |
-2.15 |
-7.17 |
-12.12 |
1.54 |
-6.21 |
-17.02 |
-12.15 |
-1.2 |
-13.31 |
12.5 |
| Weighted Average Shares
Out |
$11.97 M
|
$1.93 M
|
$656,933.00
|
$530,803.00
|
$530,943.00
|
$532,264.00
|
$506,919.00
|
$480,801.00
|
$502,463.00
|
$502,342.00
|
| Weighted Average Shares
Out Diluted |
$11.97 M
|
$1.93 M
|
$656,933.00
|
$532,311.00
|
$530,943.00
|
$532,264.00
|
$511,200.00
|
$502,592.00
|
$502,463.00
|
$503,212.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
